Item 4 of the Schedule 13D is hereby amended to add the following information:
In connection with the execution and delivery of the Agreement and Plan of Merger (the “Merger Agreement”), dated as of July 8,2019, by and among the Issuer, AdaptHealth Holdings, LLC, a Delaware limited liability company (“AdaptHealth”), BM AH Holdings, LLC, a Delaware limited liability company, Access Point Medical, Inc, a Delaware corporation, DFB Merger Sub LLC, a Delaware limited liability company, AH Representative LLC, a Delaware limited liability company, and, solely for the limited purposes set forth therein, BlueMountain Foinaven Master Fund L.P., a Cayman Islands exempted limited partnership, BMSB L.P., a Delaware limited partnership, BlueMountain Fursan Fund L.P., a Cayman Islands exempted limited partnership, and Clifton Bay Offshore Investments, L.P., a British Virgin Islands limited partnership, the Sponsor entered into a letter agreement, dated July 8,2019 (the “Letter Agreement”), pursuant to which the Sponsor agreed to transfer, immediately prior to the consummation of the transactions contemplated by the Merger Agreement and for no consideration, 2,500,000 Founder Shares and 1,733,333 Private Placement Warrants to AdaptHealth.
On October 15,2019, the parties to the Merger Agreement entered into Amendment No. 1 to the Merger Agreement (the “Merger Agreement Amendment”). In connection with the execution and delivery of the Merger Agreement Amendment, the Sponsor entered into an amended and restated letter agreement (the “Amended Letter Agreement”) pursuant to which the Sponsor agreed to transfer, immediately prior to the consummation of the transactions contemplated by the Merger Agreement and the Merger Agreement Amendment and for no consideration, between 2,437,500 to 2,500,000 Founder Shares and between 1,690,000 to 1,733,333 Private Placement Warrants to AdaptHealth (or such equityholders or employees of AdaptHealth as AdaptHealth shall designate prior to the closing of the transactions contemplated by the Merger Agreement and Merger Agreement Amendment) immediately prior to such closing. The number of Founder Shares and Private Placement Warrants to be transferred will be determined based on the number of shares purchased pursuant to an Amended and Restated Subscription Agreement, dated as of October 15,2019, among the Issuer, Deerfield Private Design Fund IV, L.P. and RAB Ventures (DFB) LLC, which was entered into by the parties thereto in connection with the entry into the Merger Agreement Amendment.